Sandoz a confirmé que la Commission européenne a accordé l'autorisation de mise sur le marché pour Ondibta® , une solution ...

Gan & Lee Pharmaceuticals a annoncé la nomination du Dr John Wang au poste de vice-président principal et directeur de la ...

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives used a conference presentation to highlight the company’s shift toward ...

This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

A new analysis from Vizient ® shows that drug manufacturers are adjusting pricing strategies in markedly different ways ahead of upcoming Medicare Drug Price Negotiation Program (MDPNP) changes under ...

Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday.  How much those savings will be passed on to Medicare Part D and applicable Advantage plan enrollees is ...

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

Background: Real-world studies on insulin degludec/aspart (IDegAsp) have been conducted in some Southeast Asian populations; however, data specific to Indonesia remain limited. The aim of this study ...

Members of the editorial and news staff of the Los Angeles magazine and the Engine Vision Media Network were not involved in the creation of this content. A new agreement between Biocon Biologics Ltd.